HLA-G and arthritic joint disease: In mice, recombinant sHLA-G and synthetic HLA-G molecules have been shown to inhibit the early stages of arthritis in a rheumatoid arthritis disease model and to significantly prolong the acceptance of skin grafts (104, 105).